Swiss firm digitising treatment of type 2 diabetes through personalised behavior change programmes secures €19M

Recently, Oviva has raised $21 million (approx €19 million) in Series B funding led by MTIP with participation from new investor Earlybird and existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech.

This Swiss firm digitising treatment of type 2 diabetes through personalised behavior change programmes secures €19M

https://dlife.com/behavior-change-company-raises-21m-to-roll-out-digital-diabetes-treatment-in-europe/